Adenovirus E1a protein enhances the cytotoxic effects of the herpes thymidine kinase-ganciclovir system
Open Access
- 21 January 2003
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 10 (2) , 152-160
- https://doi.org/10.1038/sj.cgt.7700550
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Retrovirus-mediated transfer of the herpes simplex virus thymidine kinase and connexin26 genes in pancreatic cells results in variable efficiency on the bystander killing: Implications for gene therapyInternational Journal of Cancer, 2001
- Characterization of Herpes Simplex Viruses Selected in Culture for Resistance to Penciclovir or AcyclovirJournal of Virology, 2001
- Therapy of peritoneal carcinomatosis from colon cancer with oncolytic adenovirusesThe Journal of Gene Medicine, 2000
- Replicative adenoviruses for cancer therapyNature Biotechnology, 2000
- Prodrug-activating systems in suicide gene therapyJournal of Clinical Investigation, 2000
- Replication-selective adenoviruses as oncolytic agentsJournal of Clinical Investigation, 2000
- Enhancement of the Herpes Simplex Virus Thymidine Kinase/Ganciclovir Bystander Effect and Its Antitumor Efficacy In Vivo by Pharmacologic Manipulation of Gap JunctionsHuman Gene Therapy, 1998
- Synergistic Anticancer Effects of Ganciclovir/Thymidine Kinase and 5-Fluorocytosine/Cytosine Deaminase Gene TherapiesJNCI Journal of the National Cancer Institute, 1998
- An Adenovirus Mutant That Replicates Selectively in p53- Deficient Human Tumor CellsScience, 1996
- Acyclic Guanosine Analogs Inhibit DNA Polymerases .alpha., .delta., and .epsilon. with Very Different Potencies and Have Unique Mechanisms of ActionBiochemistry, 1995